Brief: Astrazeneca Reports 9.9% Passive Stake In Monopar Therapeutics As Of Oct 23 - SEC Filing
28/10/2024 10:21
Oct 28 (Reuters) -
* ASTRAZENECA REPORTS 9.9% PASSIVE STAKE IN MONOPAR
THERAPEUTICS
AS OF OCT 23 - SEC FILING
Source text: ID:n0001104659-24-111584
((Reuters.Briefs@thomsonreuters.com))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla